Загрузка...
Raltegravir in the management of HIV-infected patients
Raltegravir has recently been licensed for the treatment of HIV-1 infection. Currently its use is limited to treatment-experienced patients and subjects with resistant virus. In addition to its activity in the setting of resistance and treatment failure, it appears to have great potential for first-...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761196/ https://ncbi.nlm.nih.gov/pubmed/19920914 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|